Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine in Advanced BRAF-like Colon Cancer
NCT03482362Phase 2Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in colon cancer, sponsored by Netherlands Cancer Institute. Started Mar 2018; status: completed.
02
Drugs
vinorelbine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03482362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482362.